Barry Stein

Barry D. Stein, B.Com., B.C.L., LL.B., graduated from McGill University and has been a member of the Bar of Quebec since 1981.  

Barry is the president and CEO of Colorectal Cancer Canada and a Lawyer in Montreal, Quebec, Canada. He sits on the Board of Directors of several corporations, not-for-profit organisations and foundations including Colorectal Cancer Canada, Exactis Innovation, the Canadian Personalized Healthcare Innovation Network (CPHIN), Le Consortium de recherche en oncologie clinique du Québec (observer) (Q-CROC) and From Testing to Targeted Treatments (FT3). He is also on the governing council of CANTRAIN the Canadian Consortium of Clinical Trial Training platform and on the Board of Directors of DNA to RNA— An inclusive Canadian Approach to Genomic-based RNA Therapeutics (D2R) based at McGill University Research Institute.  

As a survivor of metastatic colorectal cancer diagnosed in 1995, Barry was obliged to seek health care outside of Canada to fight his disease. His judgement, obtained in the Superior Court of Quebec in 1999, still serves as a leading precedent in Canada for the reimbursement of out of country health care.